2m 2m 2m 2m 2m 2m 2m
TREACE MED CNCPT (TMCI)
NASDAQ
$4.52+$0.005 (+0.11%)
Price as of Sep 11, 2026 7:30 PM EDT- $293.3MMarket Cap
- -37.53%1-Year Change
- Medical DevicesIndustry
TREACE MED CNCPT (TMCI)
$4.52+$0.005 (+0.11%)
TMCI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.51 | ||
Change | +$0.16 (+3.68%) | ||
Open | $4.55 | ||
High | $4.55 | ||
Low | $4.37 | ||
Previous Close | $4.35 | ||
Volume | 147,536 | ||
30-Day Average Volume | 292,193 | ||
1-Week Change | -6.24% | ||
1-Month Change | -4.85% | ||
1-Year Change | -37.53% | ||
3-Year Change | -68.24% | ||
5-Year Change | -83.50% | ||
Fundamentals | |||
Shares Outstanding | 65.0M | ||
Total Assets | $181.1M | ||
Market Cap | $293.3M | ||
Enterprise Value | $339.9M | ||
Period: QTR TTM FY | |||
Revenue | $45.4M | ||
Net Income | -$15.9M | ||
Free Cash Flow | -$6.9M | ||
EBIT | -$14.3M | ||
EBITDA | -$12.4M | ||
Net Working Capital | $79.0M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 4 | ||
P/E | -19 | ||
PEG | -1 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue